- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/45 - Non-condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
Patent holdings for IPC class A61K 31/45
Total number of patents in this class: 548
10-year publication summary
|
32
|
48
|
54
|
42
|
37
|
42
|
42
|
51
|
34
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celgene Corporation | 1411 |
20 |
| Amicus Therapeutics, Inc. | 354 |
19 |
| Dana-Farber Cancer Institute, Inc. | 2662 |
10 |
| Bristol-myers Squibb Company | 4729 |
8 |
| Amgen Inc. | 4425 |
7 |
| The Regents of the University of California | 20720 |
6 |
| Boehringer Ingelheim International GmbH | 4493 |
6 |
| Bpcr Limited Partnership | 35 |
6 |
| Baylor College of Medicine | 1001 |
5 |
| Epizyme, Inc. | 359 |
5 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1018 |
5 |
| Kymera Therapeutics, Inc. | 261 |
5 |
| C4 Theraprutics, Inc. | 64 |
5 |
| Arvinas Operations, Inc. | 261 |
5 |
| Novartis AG | 10263 |
4 |
| F. Hoffmann-La Roche AG | 7836 |
4 |
| Hoffmann-La Roche Inc. | 3783 |
4 |
| Genentech, Inc. | 4099 |
4 |
| Board of Regents, The University of Texas System | 6102 |
4 |
| The Johns Hopkins University | 5875 |
4 |
| Other owners | 412 |